Title Differential impact of valproic acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 expression in adult glioblastoma cells /
Authors Juknevičienė, Milda ; Balnytė, Ingrida ; Valančiūtė, Angelija ; Alonso, Marta Marija ; Preikšaitis, Aidanas ; Sužiedėlis, Kęstutis ; Stakišaitis, Donatas
DOI 10.3390/biomedicines12071416
Full Text Download
Is Part of Biomedicines.. Basel : MDPI. 2024, vol. 12, iss. 7, art. no. 1416, p. [1-12].. eISSN 2227-9059
Keywords [eng] adult glioblastoma ; CDH1 ; CDH2 ; KCC2 ; NKCC1 ; SLC5A8 ; T98G cell ; U87 MG cell ; valproic acid
Abstract [eng] Valproic acid (VPA) has anticancer, anti-inflammatory, and epigenetic effects. The study aimed to determine the expression of carcinogenesis-related SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 in adult glioblastoma U87 MG and T98G cells and the effects of 0.5 mM, 0.75 mM, and 1.5 mM doses of VPA. RNA gene expression was determined by RT-PCR. GAPDH was used as a control. U87 and T98G control cells do not express SLC5A8 or CDH1. SLC12A5 was expressed in U87 control but not in T98G control cells. The SLC12A2 expression in the U87 control was significantly lower than in the T98G control. T98G control cells showed significantly higher CDH2 expression than U87 control cells. VPA treatment did not affect SLC12A2 expression in U87 cells, whereas treatment dose-dependently increased SLC12A2 expression in T98G cells. Treatment with 1.5 mM VPA induced SLC5A8 expression in U87 cells, while treatment of T98G cells with VPA did not affect SLC5A8 expression. Treatment of U87 cells with VPA significantly increased SLC12A5 expression. VPA increases CDH1 expression depending on the VPA dose. CDH2 expression was significantly increased only in the U87 1.5 mM VPA group. Tested VPA doses significantly increased CDH2 expression in T98G cells. When approaching treatment tactics, assessing the cell’s sensitivity to the agent is essential.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2024
CC license CC license description